Advertisement

Topics

Ionis Licenses Novel Antisense Drug to Treat CNM to Dynacure

15:00 EST 15 Nov 2017 | Drug Discovery Development

Dynacure will now assume all development and commercialization responsibilities for the program.
Contributed Author: 
Ionis Pharmaceuticals
Topics: 

Original Article: Ionis Licenses Novel Antisense Drug to Treat CNM to Dynacure

NEXT ARTICLE

More From BioPortfolio on "Ionis Licenses Novel Antisense Drug to Treat CNM to Dynacure"

Advertisement
Quick Search
Advertisement
Advertisement